EUCTR2012-001909-24-NLActive, not recruitingPhase 1
A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after Transplantation - Spartacus
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Patients = 18 years
- •Patients admitted to the ICC of UMCU after heart or lung transplantation
- •Treated with tacrolimus (Prograft®; Astellas Pharma Europe)
- •Informed consent obtained
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Patients < 18 years
- •Patients who die within one day after admission to the ICC of UMCU
- •Withdrawal of informed consent
- •Allergy towards tacrolimus or macrolides
- •Patients on total parenteral nutrition
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A multicenter, open, prospective observational study to confirm the clinical efficacy and safety after drug change in patients with degenerative arthritis (spondyloarthritis, knee arthritis) treated with anti-inflammatory analgesicsDiseases of the musculoskeletal system and connective tissueKCT0007770Yonsei University Health System, Severance Hospital800
Recruiting
Phase 4
Centralized monitoring study for safety of Traditional Chinese Medicine granulesadverse drug reactionITMCTR2000003180First Affiliated Hospital of Guang zhou University of Chinese Medicine
Completed
Not Applicable
A prospective, open label, multi-centre, observational, post-market study evaluating Juvéderm® Volift with Lidocaine for the correction of moderate to severe nasolabial folds (NLF)gezichtverouderingdermal fillersfacial agingNL-OMON37130Allergan Pharmaceuticals Ireland23
Recruiting
Not Applicable
An observational registry study of ISAR SUMMIT coronary stent system in coronary artery diseased patients of Indian populatioCTRI/2022/07/044472Dr Praveen Chandra
Completed
Not Applicable
Pharmacokinetics of tacrolimus in the first days after heart and lung transplantation.transplantationtacrolimuspharmacokineticsNL-OMON20956Prof. J. Meulenbelt, MD, PhDHead of department of National Poisons Information Center Intensive Care Center of the division of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Center of UtrechtP.O. Box 855003508 GA UtrechtThe Netherlands30